Dél-afrikai Köztársaság - angol - South African Health Products Regulatory Authority (SAHPRA)

viatris healthcare (pty) ltd - nasal spray - 1,0 mg 0,365 mg - each 1,0 g suspension contains azelastine hydrochloride 1,0 mg fluticasone propionate 0,365 mg

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

provident dental pty ltd - 47144 - dental chair, electric - a mains electricity device designed to support a patient in a seated position to facilitate dental examination, treatment, and/or minor surgery procedures. it is adjustable in height to enable healthcare staff to perform procedures while standing and sitting. it includes head and armrests, a reclining back that may be tilted from a vertical to a horizontal position, and has rotating capabilities; some types can be programmed to several standard positions. device intended for dental examination and/or treatment used by dentists and other dental practitioners. components of the chair, included are lights, irrigation systems, and electorally powered components such as dental drill systems.

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

care pharmaceuticals pty ltd - ketotifen fumarate, quantity: 0.345 mg/ml (equivalent: ketotifen fumarate, qty 0.25 mg/ml; equivalent: ketotifen, qty 0.25 mg/ml) - eye drops, solution - excipient ingredients: glycerol; water for injections; sodium hydroxide - the symptomatic short term treatment of seasonal allergic conjuctivitis in adults and children 3 years or older.

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

care pharmaceuticals pty ltd - ketotifen fumarate, quantity: 0.345 mg/ml (equivalent: ketotifen fumarate, qty 0.25 mg/ml; equivalent: ketotifen, qty 0.25 mg/ml) - eye drops, solution - excipient ingredients: water for injections; glycerol; sodium hydroxide; benzalkonium chloride - the symptomatic short term treatment of seasonal allergic conjuctivitis in adults and children 3 years or older.

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

novo nordisk pharmaceuticals pty ltd - eptacog alfa (activated); histidine -

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - rotavirus -

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - sildenafil citrate -

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

ix biopharma pty ltd - sildenafil citrate, quantity: 70.24 mg (equivalent: sildenafil, qty 50 mg) - capsule - excipient ingredients: titanium dioxide; lactose monohydrate; magnesium stearate; sunset yellow fcf; croscarmellose sodium; tartrazine; gelatin; silicon dioxide; sodium lauryl sulfate - sildenafil is indicated for the treatment of erectile dysfunction in adult males. ,sildenafil is not indicated for use by women.

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

ix biopharma pty ltd - sildenafil citrate, quantity: 35.12 mg (equivalent: sildenafil, qty 25 mg) - capsule - excipient ingredients: lactose monohydrate; magnesium stearate; croscarmellose sodium; titanium dioxide; gelatin; silicon dioxide; sodium lauryl sulfate - sildenafil is indicated for the treatment of erectile dysfunction in adult males. ,sildenafil is not indicated for use by women.

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

ix biopharma pty ltd - sildenafil citrate, quantity: 70.24 mg (equivalent: sildenafil, qty 50 mg) - capsule - excipient ingredients: croscarmellose sodium; magnesium stearate; lactose monohydrate; titanium dioxide; tartrazine; sunset yellow fcf; gelatin; silicon dioxide; sodium lauryl sulfate - sildenafil is indicated for the treatment of erectile dysfunction in adult males. ,sildenafil is not indicated for use by women.